FindTrial
Sign In

A retrospective study based on medical records: The comparative study of clinicopathological features, microenvironment composition and prognosis of primary cutaneous and systemic anaplastic large cell lymphoma

The comparative study of clinicopathological features, microenvironment composition and prognosis of primary cutaneous and systemic anaplastic large cell lymphoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800019163
Enrollment
Unknown
Registered
2018-10-29
Start date
2018-11-01
Completion date
Unknown
Last updated
2018-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cutaneous anaplastic large cell lymphoma

Interventions

PC-ALCL group:None
Cutaneous S-ALK-ALCL group:None
Cutaneous S-ALK+ALCL group:None
Nodal S-ALK-ALCL group:None

Sponsors

Department of Dermatovenerology, West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 88 Years

Inclusion criteria

Inclusion criteria: All patients with cutaneous ALCL that firstly presented in skin, or ALK negative expressed nodal ALCL diagnosed for the first time in West China Hospital, Sichuan University from January 2002 to January 2017.

Exclusion criteria

Exclusion criteria: 1) Secondary to other lymphohematopoietic tumors/lymphoid proliferative diseases; 2) Patients of recurrence, or have received special treatments such as chemotherapy or radiotherapy; 3) Patients with immunodeficiency or immunosuppressive status.

Design outcomes

Primary

MeasureTime frame
Clinical characteristics;Pathological features;Number of tumor microenvironment-related cells (TAMs, MDSCs and CD8+T cells);Survival time;—

Countries

China

Contacts

Public ContactLin WANG

Department of Dermatovenerology, West China Hospital, Sichuan University,

lkzwl@126.com+86 18980601701

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026